Pieris Pharmaceuticals Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Date | Value | Name | Entity | Role | Shares | Max Price |
---|---|---|---|---|---|---|
12 Aug 24 | BuyUS$92,326 | ADAR1 Capital Management, LLC | Company | 6,000 | US$15.88 |
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Owner Type | Number of Shares | Ownership Percentage |
---|---|---|
Individual Insiders | 18,059 | 1.37% |
Institutions | 104,686 | 7.93% |
Hedge Funds | 494,056 | 37.4% |
General Public | 703,439 | 53.3% |
Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 6.8%.
Top Shareholders
Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
---|---|---|---|---|---|---|
257,626 | US$4.5m | 0% | 0.11% | |||
144,641 | US$2.5m | 0% | 0.44% | |||
91,789 | US$1.6m | 0% | no data | |||
43,499 | US$752.5k | -60.4% | 0.29% | |||
17,185 | US$297.3k | 0% | no data | |||
12,975 | US$224.5k | 0.04% | no data | |||
11,471 | US$198.4k | -35.8% | no data | |||
11,342 | US$196.2k | 0% | no data | |||
10,827 | US$187.3k | -9.99% | no data | |||
10,623 | US$183.8k | 9.98% | no data | |||
1,726 | US$29.9k | 166% | no data | |||
1,108 | US$19.2k | 0.09% | no data | |||
334 | US$5.8k | -37.5% | no data | |||
323 | US$5.6k | 0.62% | no data | |||
250 | US$4.3k | 0% | no data | |||
250 | US$4.3k | 0% | no data | |||
241 | US$4.2k | 0% | no data | |||
138 | US$2.4k | -12.7% | no data | |||
82 | US$1.4k | -3.53% | no data | |||
75 | US$1.3k | 0% | no data | |||
63 | US$1.1k | 1.61% | no data | |||
60 | US$1.0k | 0% | no data | |||
58 | US$1.0k | 0% | no data | |||
56 | US$968.4 | 0% | no data | |||
27 | US$468.2 | 12.5% | no data |